IL-17A and IL-17F Gene expression is strongly induced in the Mucosa of H. pylori-infected subjects from Kenya and Germany

Scandinavian Journal of Immunology

Volumn 72, Issue 6, 2010, Pages 522-528

  Kimang'A, A ^a,d   Revathi, G ^b   Kariuki, S ^c   Sayed, S ^b   Devani, S ^b   Vivienne, M ^a   Kuester, D ^d   Monkemuller K ^d   Malfertheiner, P ^d   Wex, T ^d  

^a JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Kenya)

^b AGA KHAN UNIVERSITY   (Kenya)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 33; INTERLEUKIN 8;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CHILD; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GERMANY; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; KENYA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN FOLDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; STOMACH MUCOSA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DYSPEPSIA; ESOPHAGITIS, PEPTIC; FEMALE; GASTRIC MUCOSA; GENE EXPRESSION REGULATION; GERMANY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFANT; INTERLEUKIN-17; KENYA; MALE; MIDDLE AGED; UP-REGULATION;

EID: 78149256647     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02469.x     Document Type: Article

References (46)

1. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008;134:306-23.
2. Chmiela M, Michetti P. Inflammation, immunity, vaccines for Helicobacter infection. Helicobacter 2006;11 (Suppl. 1):21-6.
3. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology 2009;136:1863-73.
4. Smith MF Jr, Mitchell A, Li G et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 2003;278:32552-60.
5. Moran AP, Hynes SO, Heneghan MA. Mimicry of blood group antigen A by Helicobacter mustelae and H. pylori. Gastroenterology 1999;116:504-5.
6. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003;301:1099-102.
7. Schmees C, Prinz C, Treptau T et al. Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase. Gastroenterology 2007;132:1820-33.
8. Wunder C, Churin Y, Winau F et al. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med 2006;12:1030-8.
9. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996;20:1161-81.
10. D'Elios MM, Andersen LP. Helicobacter pylori inflammation, immunity, and vaccines. Helicobacter 2007;12 (Suppl. 1):15-9.
11. Goll R, Gruber F, Olsen T et al. Helicobacter pylori stimulates a mixed adaptive immune response with a strong T-regulatory component in human gastric mucosa. Helicobacter 2007;12:185-92.
12. Kandulski A, Malfertheiner P, Wex T. Role of regulatory T-cells in H. pylori-induced gastritis and gastric cancer. Anticancer Res 2010;30:1093-103.
13. Eaton KA, Mefford M, Thevenot T. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol 2001;166:7456-61.
14. Robinson K, Kenefeck R, Pidgeon EL et al. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut 2008;57:1375-85.
15. Arnold I, Lee JY, Amieva MR et al. Tolerance rather than immunity protects from Helicobacter pylori -induced gastric preneoplasia. Gastroenterology 2010; doi: [Epub ahead of print].
16. Kao JY, Zhang M, Miller MJ et al. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 2010;138:1046-54.
17. Caruso R, Fina D, Paoluzi OA et al. IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur J Immunol 2008;38:470-8.
18. Raghavan S, Ostberg AK, Flach CF et al. Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach. Infect Immun 2010;78:4251-60.
19. Shi Y, Liu XF, Zhuang Y et al. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol 2010;184:5121-9.
20. Khamri W, Walker MM, Clark P et al. Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4 + T lymphocytes. Infect Immun 2010;78:845-53.
21. The International Response to Helsinki VI - The WMA's Declaration of Helsinki on Ethical Principles for Medical Research Involving Human Subjects, as adopted by the 52nd WMA General Assembly, Edinburgh, 2000.
22. Wex T, Mönkemüller K, Kuester D, Fry L, Kandulski A, Malfertheiner P. Zonulin is not increased in the cardiac and esophageal mucosa of patients with gastroesophageal reflux disease. Peptides 2009;30:1082-7.
23. Vakil N, Van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20.
24. Lundell L, Dent J, Bennett J. Endoscopic assessment of esophagitis: clinical and functional correlates and further validation of Los Angeles classification. Gut 1999;45:172-80.
25. Wex T, Treiber G, Lendeckel U, Malfertheiner P. A Two-Step Method for the Extraction of High-Quality RNA from Endoscopic Biopsies. Clin Chem Lab Med 2003;41:1033-7.
26. Calvet X, Sánchez-Delgado J, Montserrat A et al. Accuracy of diagnostic tests for Helicobacter pylori: a reappraisal. Clin Infect Dis 2009;48:1385-91.
27. Shimada M, Ando T, Peek RM et al. Helicobacter pylori infection upregulates interleukin-18 production from gastric epithelial cells. Eur J Gastroenterol Hepatol 2008;20:144-50.
28. Ye ZB, Ma T, Li H, Jin XL, Xu HM. Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma. World J Gastroenterol 2007;13:1747-51.
29. Dzierzanowska-Fangrat K, Michalkiewicz J, Cielecka-Kuszyk J et al. Enhanced gastric IL-18 mRNA expression in Helicobacter pylori-infected children is associated with macrophage infiltration, IL-8, and IL-1 beta mRNA expression. Eur J Gastroenterol Hepatol 2008;20:314-9.
30. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008;223:20-38.
31. Chad AH, George PC, Ross CG, Joel R, David AL, Paul TM. Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol 2008;84:631-43.
32. Mitchell HM, Ally R, Ahmed R, Segal I. The host immune response to H. pylori infection in Sowetans is significantly different from that in western subjects. Afr Med J 2000;90:640.
33. Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 2010;159:109-19.
34. Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity 2004;21:467-76.
35. Otani K, Watanabe T, Tanigawa T et al. Anti-inflammatory effects of IL-17A on Helicobacter pylori-induced gastritis. Biochem Biophys Res Commun 2009;382:252-8.
36. Shiomi S, Toriie A, Imamura S et al. IL-17 is involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Helicobacter 2008;13:518-24.
37. Caruso R, Pallone F, Monteleone G. Emerging role of IL-23/IL-17 axis in H pylori-associated pathology. World J Gastroenterol 2007;13:5547-51.
38. Mizuno T, Ando T, Nobata K et al. Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonization. World J Gastroenterol 2005;11:6305-11.
39. Luzza F, Parrello T, Monteleone G et al. Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J Immunol 2000;165:5332-7.
40. Sugimoto M, Ohno T, Graham DY et al. Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils. Cancer Sci 2009;100:2152-9.
41. Jafarzadeh A, Mirzaee V, Ahmad-Beygi H et al. Association of the CagA status of Helicobacter pylori and serum levels of interleukin (IL)-17 and IL-23 in duodenal ulcer patients. J Dig Dis 2009;10:107-12.
42. Algood HM, Allen SS, Washington MK et al. Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection. J Immunol 2009;183:5837-46.
43. Velin D, Favre L, Bernasconi E et al. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 2009;136:2237-46.
44. DeLyria ES, Redline RW, Blanchard TG. Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 2009;136:247-56.
45. Wu X, Zeng Z, Chen B et al. Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer. Int J Cancer 2010;127:86-92.
46. Wex T, Bornschein J, Malfertheiner P. Host polymorphisms of immune regulatory genes as risk factors for gastric cancer. Minerva Gastroenterol Dietol 2009;55:395-408.